Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?

Supportive Care in Cancer

Volumn 12, Issue 4, 2004, Pages 263-267

  Dagdemir, Ayhan ^a   Yildirim, Hasan ^a   Aliyazicioglu, Yuksel ^a   Kanber, Yilmaz ^a   Albayrak, Davut ^a   Acar, Sabri ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

D xylose; High dose; Malabsorption; Methotrexate; Prevention; Vitamin A

Indexed keywords

METHOTREXATE; RETINOL; RETINOL BINDING PROTEIN; XYLOSE;

ADOLESCENT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER PATIENT; CARBOHYDRATE ABSORPTION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; DRUG RESEARCH; FEMALE; HUMAN; INTESTINE MUCOSA; LEUKEMIA; LYMPHOMA; MALABSORPTION; MALE; MUCOSA INFLAMMATION; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN BLOOD LEVEL; SIDE EFFECT; SKIN TOXICITY; STATISTICAL SIGNIFICANCE; TREATMENT PLANNING;

ADOLESCENT; ANTIMETABOLITES, ANTINEOPLASTIC; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA, NON-HODGKIN; MALABSORPTION SYNDROMES; MALE; METHOTREXATE; PROSPECTIVE STUDIES; PROTECTIVE AGENTS; RETINOL-BINDING PROTEINS; VITAMIN A; XYLOSE;

EID: 2442718754     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-004-0591-8     Document Type: Article

References (26)

1. Almekinder J, Manda W, Soko D, Lan Y, Hoover DR, Semba RD (2000) Evaluation of plasma retinol-binding protein as a surrogate measure for plasma retinol concentrations. Scand J Clin Lab Invest 60:199-203
2. Balis FM, Holcenberg JS, Poplack DG (1997) General principles of chemotherapy. In: Pizzo PA, Poplack DG (eds) Principles and practice of pediatric oncology, 3rd edn, Lippincot, Philadelphia, pp 215-272
3. Barclay AJ, Foster A, Sommer A (1987) Vitamin A supplements and mortality related to measles: a randomized clinical trial. BMJ 294(6567): 294-296
4. Bernard A, Dandrifosse G, Romain N, Forget P (1989) Effect on the intestinal mucosa of PGE2-treated rats. Life Sciences 45:2591-2603
5. Craig R, Atkinson A (1988) D-xylose testing: A review. Gastroenterology 95:223-231
6. DeLap R (1996) Antimetabolic agents. In: Kirkwood J, Lotze M, Yasko J (eds) Current cancer therapeutics, 2nd edn, Current Medicina, Philadelphia, pp 50-62
7. Eledrisi SM, Mc Kinney K Vitamin A toxicity. http://www.emedicine.com/ med/topic2382.htm.
8. Hasan M and Finucane P (1993) Intestinal malabsorption presenting with night blindness. Br J Clin Pract 47:275-276
9. Hatun S, Tezic T (1995) Vitamin A status of healthy infants in Ankara, Turkey. Turkish Journal of Pediatrics 37:187-192
10. Hatun S, Tezic T, Kunak B, Cengiz AB (1995) Vitamin A levels of children with measles in Ankara, Turkey. Turk J Pediatr 37:193-200
11. Hussey GD, Klein M (1990) A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med 323:160-164
12. Koninkx JF, Stemerdink AF, Mirck MH, Egberts HJ, van Dijk JE, Mauwen JM (1988) Histochemical changes in the composition of mucins in goblet cells during methotrexate-induced mucosal atrophy in rats. Exp Pathol 34:125-133
13. Kosakai Y, Horie T, Awazu S (1991) Protective effect of vitamin A against the methotrexate-induced damage to small intestine: A study on the crypt cells. Pharmacol Toxicol 69:291-295
14. Maldonado Y (2000) Measles. In: Nelson WE, Behrman RE, Kliegman RM, Jenson HB (eds) Textbook of pediatrics, 16th ed, Saunders, Philadelphia, pp 946-950
15. Nagai Y, Horie T, Awazu S (1993) Vitamin A, a useful biochemical modulator capable of preventing intestinal damage during methotrexate treatment. Pharmacol Toxicol 73:69-74
16. National Cancer Institute (1999) Cancer therapy evaluation program, common toxicity criteria, version 2.0
17. Ottery FD (1994) Rethinking nutritional support of the cancer patient: the new of nutritional oncology. Semin Oncol 21:770-778
18. Pearson AD, Craft AW, Pledger JV et al. (1984) Small bowel function in acute lymphoblastic leukemia. Arch Dis Child 59:460-465
19. Quilitz R (1995) Modulation of chemotherapy-induced mucositis. Cancer Control 2:452-459
20. Sibulesky L, Hayes KC, Pronczuk A, Weigel-DiFranco C, Rosner B, Berson EL (1999) Safety of <7500RE (25000 IU) vitamin A daily in adults with retinitis pigmentosa. Am J Clin Nutr 69:656-663
21. Takeuchi H, Kosakai Y, Tsurui K, Hasegawa K, Horie T, Awazu S (1989) Change in small intestine brush border membranes of rats following methotrexate administration. Pharmacol Toxicol 65:269-275
22. Thatcher N, Blackledge G, Crowther D (1980) Advanced recurrent squamous cell carcinoma of the head and neck. Result of chemotherapeutic regimen with adriamycin, bleomycin, 5-fluoro-uracil, methotrexate and vitamin A. Cancer 46:1324-1328
23. Tsurui K, Kosakai Y, Horie T, Awazu S. (1990) Vitamin A protects small intestine from methotrexate-induced damage in rats. The J Pharmacol Exp Ther 253:1278-1284
24. Warden R, Noltrop RS, Francis JL et al (1997) Vitamin A deficiency exacerbates methotrexate-induced jejunal injury in rats. J Nutr 127:770-776
25. Yamamoto J, Nagai Y, Horie T, Awazu S (1993) Effect of vitamin A on methotrexate cytotoxicity in L1210 murine leukemia cells in culture. Cancer Chemother Pharmacol 32:263-267
26. Yamamoto J, Horie T, Awazu S (1997) Amelioration of methotrexate-induced malabsorption by vitamin A. Cancer Chemother Pharmacol 39:239-244